trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Breast Neoplasms D001943 24 associated lipids
Neoplasms D009369 13 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Body Weight D001835 333 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Carcinoma D002277 18 associated lipids
Ureteral Obstruction D014517 10 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Hypersensitivity D006967 22 associated lipids
Osteosarcoma D012516 50 associated lipids
Brain Neoplasms D001932 15 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Melanoma D008545 69 associated lipids
Muscular Dystrophies D009136 10 associated lipids
Asthma D001249 52 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Intellectual Disability D008607 13 associated lipids
Glioma D005910 112 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Endometriosis D004715 29 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Adrenoleukodystrophy D000326 29 associated lipids
Prostatic Hyperplasia D011470 20 associated lipids
Alzheimer Disease D000544 76 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Leukemia D007938 74 associated lipids
Neuroblastoma D009447 66 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Myeloproliferative Disorders D009196 5 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Fibrosis D005355 23 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Carcinoma, Renal Cell D002292 12 associated lipids
Immunologic Deficiency Syndromes D007153 8 associated lipids
Leukemia, Promyelocytic, Acute D015473 3 associated lipids
Stroke D020521 32 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Sharifulina SA et al. Epigenetic regulation of death of crayfish glial cells but not neurons induced by photodynamic impact. 2014 Brain Res. Bull. pmid:24502940
Nieto-Pelegrin E et al. Nck adaptors, besides promoting N-WASP mediated actin-nucleation activity at pedestals, influence the cellular levels of enteropathogenic Escherichia coli Tir effector. 2014 Cell Adh Migr pmid:25482634
An JH et al. The expression of p21 is upregulated by forkhead box A1/2 in p53-null H1299 cells. 2014 FEBS Lett. pmid:25281925
Han RF et al. Trichostatin A induces mesenchymal-like morphological change and gene expression but inhibits migration and colony formation in human cancer cells. 2014 Mol Med Rep pmid:25269990
Boucher J et al. Insulin and insulin-like growth factor 1 receptors are required for normal expression of imprinted genes. 2014 Proc. Natl. Acad. Sci. U.S.A. pmid:25246545
Wang BY et al. Epigenetic suppression of hippocampal BDNF mediates the memory deficiency induced by amyloid fibrils. 2014 Pharmacol. Biochem. Behav. pmid:25242807
Wang B et al. Reversion of trichostatin A resistance via inhibition of the Wnt signaling pathway in human pancreatic cancer cells. 2014 Oncol. Rep. pmid:25224651
Svegliati S et al. Oxidative DNA damage induces the ATM-mediated transcriptional suppression of the Wnt inhibitor WIF-1 in systemic sclerosis and fibrosis. 2014 Sci Signal pmid:25185156
Lu HG et al. TET1 partially mediates HDAC inhibitor-induced suppression of breast cancer invasion. 2014 Mol Med Rep pmid:25175940
Zohre S et al. Trichostatin A-induced apoptosis is mediated by Kruppel-like factor 4 in ovarian and lung cancer. 2014 Asian Pac. J. Cancer Prev. pmid:25169491
Saini M et al. Trichostatin A alters the expression of cell cycle controlling genes and microRNAs in donor cells and subsequently improves the yield and quality of cloned bovine embryos in vitro. 2014 Theriogenology pmid:25151601
Tomioka T et al. The histone deacetylase inhibitor trichostatin A induces neurite outgrowth in PC12 cells via the epigenetically regulated expression of the nur77 gene. 2014 Neurosci. Res. pmid:25128386
Charni Chaabane S et al. PDGF-D expression is down-regulated by TGFβ in fibroblasts. 2014 PLoS ONE pmid:25280005
Knobloch J et al. Resveratrol attenuates the release of inflammatory cytokines from human bronchial smooth muscle cells exposed to lipoteichoic acid in chronic obstructive pulmonary disease. 2014 Basic Clin. Pharmacol. Toxicol. pmid:23981542
Choi DC et al. MicroRNA-7 protects against 1-methyl-4-phenylpyridinium-induced cell death by targeting RelA. 2014 J. Neurosci. pmid:25232110
Vorrink SU et al. Epigenetic determinants of CYP1A1 induction by the aryl hydrocarbon receptor agonist 3,3',4,4',5-pentachlorobiphenyl (PCB 126). 2014 Int J Mol Sci pmid:25116688
Srirattana K et al. Effects of trichostatin A on In vitro development and DNA methylation level of the satellite I region of swamp buffalo (Bubalus bubalis) cloned embryos. 2014 J. Reprod. Dev. pmid:24909601
Wang Y et al. Effects of histone deacetylase inhibition on the survival, proliferation and migration of Schwann cells, as well as on the expression of neurotrophic factors and genes associated with myelination. 2014 Int. J. Mol. Med. pmid:24888454
Chan ST et al. Oral and intraperitoneal administration of quercetin decreased lymphocyte DNA damage and plasma lipid peroxidation induced by TSA in vivo. 2014 Biomed Res Int pmid:24868531
Kiliccioglu I et al. Apoptotic effects of proteasome and histone deacetylase inhibitors in prostate cancer cell lines. 2014 Genet. Mol. Res. pmid:24854658
Yang DH et al. Dynamic rearrangement of F-actin is required to maintain the antitumor effect of trichostatin A. 2014 PLoS ONE pmid:24846135
Kumafuji M et al. Mediator MED18 subunit plays a negative role in transcription via the CDK/cyclin module. 2014 Genes Cells pmid:24840924
Peiffer L et al. Trichostatin A effectively induces apoptosis in chronic lymphocytic leukemia cells via inhibition of Wnt signaling and histone deacetylation. 2014 J. Cancer Res. Clin. Oncol. pmid:24793644
Zhang Y et al. Autophagy in pulmonary macrophages mediates lung inflammatory injury via NLRP3 inflammasome activation during mechanical ventilation. 2014 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:24838752
Balmer NV et al. From transient transcriptome responses to disturbed neurodevelopment: role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects. 2014 Arch. Toxicol. pmid:24935251
Deng Y et al. [Expression of neprilysin gene is associated with methylation and histone modification on promoter in mouse neuroblastoma Neuro-2a cells]. 2014 Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi pmid:25108432
Sun S et al. Trichostatin A targets the mitochondrial respiratory chain, increasing mitochondrial reactive oxygen species production to trigger apoptosis in human breast cancer cells. 2014 PLoS ONE pmid:24626188
Fang J et al. Epigenetic modulation of neuronal apoptosis and cognitive functions in sepsis-associated encephalopathy. 2014 Neurol. Sci. pmid:23925573
Saayman S et al. An HIV-encoded antisense long noncoding RNA epigenetically regulates viral transcription. 2014 Mol. Ther. pmid:24576854
Xie L et al. Histone deacetylase inhibitors trichostatin A and vorinostat inhibit TGFβ2-induced lens epithelial-to-mesenchymal cell transition. 2014 Invest. Ophthalmol. Vis. Sci. pmid:24994865
McEachern LA and Murphy PR Chromatin-remodeling factors mediate the balance of sense-antisense transcription at the FGF2 locus. 2014 Mol. Endocrinol. pmid:24552587
Sakharkar AJ et al. Effects of histone deacetylase inhibitors on amygdaloid histone acetylation and neuropeptide Y expression: a role in anxiety-like and alcohol-drinking behaviours. 2014 Int. J. Neuropsychopharmacol. pmid:24528596
Kong Q et al. Telomere elongation facilitated by trichostatin a in cloned embryos and pigs by somatic cell nuclear transfer. 2014 Stem Cell Rev pmid:24510582
Sassi Fde A et al. Inhibitory activities of trichostatin a in U87 glioblastoma cells and tumorsphere-derived cells. 2014 J. Mol. Neurosci. pmid:24464841
Li H et al. The histone deacetylase inhibitor trichostatin a promotes totipotency in the male gametophyte. 2014 Plant Cell pmid:24464291
Xiao W et al. Trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and epithelial-mesenchymal transition in retinal pigment epithelium cells. 2014 J. Cell. Mol. Med. pmid:24456602
Maleszewska M et al. The effects of selected inhibitors of histone modifying enzyme on C6 glioma cells. 2014 Pharmacol Rep pmid:24905315
Saccone V et al. HDAC-regulated myomiRs control BAF60 variant exchange and direct the functional phenotype of fibro-adipogenic progenitors in dystrophic muscles. 2014 Genes Dev. pmid:24682306
Alcarraz-Vizán G et al. Validation of NCM460 cell model as control in antitumor strategies targeting colon adenocarcinoma metabolic reprogramming: trichostatin A as a case study. 2014 Biochim. Biophys. Acta pmid:24368265
Xie M et al. Histone deacetylase inhibition blunts ischemia/reperfusion injury by inducing cardiomyocyte autophagy. 2014 Circulation pmid:24396039
Koriyama Y et al. Neuritogenic activity of trichostatin A in adult rat retinal ganglion cells through acetylation of histone H3 lysine 9 and RARβ induction. 2014 J. Pharmacol. Sci. pmid:24389816
Liu J et al. DNA promoter and histone H3 methylation downregulate NGX6 in gastric cancer cells. 2014 Med. Oncol. pmid:24338274
Al-Rayyan N et al. 5-Aza-2-deoxycytidine and trichostatin A increase COUP-TFII expression in antiestrogen-resistant breast cancer cell lines. 2014 Cancer Lett. pmid:24513177
Yang W et al. Trichostatin A increases the levels of plasma gelsolin and amyloid beta-protein in a transgenic mouse model of Alzheimer's disease. 2014 Life Sci. pmid:24486299
Brglez V et al. Secreted phospholipases Aâ‚‚are differentially expressed and epigenetically silenced in human breast cancer cells. 2014 Biochem. Biophys. Res. Commun. pmid:24508801
Smith S et al. Histone deacetylase inhibitors selectively target homology dependent DNA repair defective cells and elevate non-homologous endjoining activity. 2014 PLoS ONE pmid:24466340
Bezecny P Histone deacetylase inhibitors in glioblastoma: pre-clinical and clinical experience. 2014 Med. Oncol. pmid:24838514
Alsarraf O et al. Acetylation: a lysine modification with neuroprotective effects in ischemic retinal degeneration. 2014 Exp. Eye Res. pmid:25064603
Kanski R et al. Histone acetylation in astrocytes suppresses GFAP and stimulates a reorganization of the intermediate filament network. 2014 J. Cell. Sci. pmid:25128567
Blank M et al. Basolateral amygdala activity is required for enhancement of memory consolidation produced by histone deacetylase inhibition in the hippocampus. 2014 Neurobiol Learn Mem pmid:24583371